BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15800405)

  • 1. Metalloporphyrins for the treatment of neonatal jaundice.
    Dennery PA
    Curr Opin Pediatr; 2005 Apr; 17(2):167-9. PubMed ID: 15800405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tin-metalloporphyrins: an answer to neonatal jaundice?
    Steffensrud S
    Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
    Kappas A; Drummond GS; Henschke C; Valaes T
    Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
    Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
    J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of metalloporphyrins for the chemoprevention of neonatal jaundice.
    Stevenson DK; Rodgers PA; Vreman HJ
    Am J Dis Child; 1989 Mar; 143(3):353-6. PubMed ID: 2644817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic treatment of neonatal jaundice. A new approach].
    Gabilan JC
    Arch Pediatr; 1998 Nov; 5(11):1274-8. PubMed ID: 9853069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for the treatment of neonatal jaundice.
    Dennery PA
    Semin Neonatol; 2002 Apr; 7(2):111-9. PubMed ID: 12208095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of severe neonatal hyperbilirubinemia.
    Drummond GS; Kappas A
    Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Kappas A
    Pediatrics; 2004 Jan; 113(1 Pt 1):119-23. PubMed ID: 14702459
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin.
    Galbraith RA; Drummond GS; Kappas A
    Pediatrics; 1992 Feb; 89(2):175-82. PubMed ID: 1734381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
    Stevenson DK; Wong RJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative metalloporphyrins for the treatment of neonatal jaundice.
    Vreman HJ; Wong RJ; Stevenson DK
    J Perinatol; 2001 Dec; 21 Suppl 1():S108-13; discussion S125-7. PubMed ID: 11803430
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of clofibrate in jaundiced term newborns.
    Mohammadzadeh A; Farhat ASh; Iranpour R
    Indian J Pediatr; 2005 Feb; 72(2):123-6. PubMed ID: 15758533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin.
    Alexander D
    Pediatrics; 2004 Jan; 113(1 Pt 1):135. PubMed ID: 14702465
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity.
    Vreman HJ; Ekstrand BC; Stevenson DK
    Pediatr Res; 1993 Feb; 33(2):195-200. PubMed ID: 8433895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.